Mycenax Biotech Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 148.315 million compared to TWD 78.060 million a year ago. Operating loss was TWD 13.892 million compared to TWD 96.375 million a year ago. Net loss was TWD 13.710 million compared to TWD 93.048 million a year ago. Basic loss per share was TWD 0.11 compared to TWD 0.73 a year ago. For the nine months, sales was TWD 487.148 million compared to TWD 259.370 million a year ago. Operating income was TWD 42.352 million compared to operating loss of TWD 190.552 million a year ago. Net income was TWD 43.335 million compared to net loss of TWD 175.502 million a year ago. Basic earnings per share was TWD 0.34 compared to basic loss per share of TWD 1.4 a year ago.